Orally Bioavailable SARS-CoV-2 Protease Inhibitors Bearing a Hydroxymethyl Ketone Warhead
Environmental stochasticity can account for patterns of within-host respiratory virus evolution
Expansion Revealing of Pathology Resolves Nanostructures Associated with Inflammatory Phenotypes in COVID-19 Decedent Human Brain Tissue
A Structural Domain in the genomic RNA of SARS-CoV-2 Folds into a Compact Granular Structure without the N protein: A Single-Molecule Fluorescence Spectroscopic Investigation
Immunological imprinting shapes the cross-reactive antibody responses to the KP.2 and LP.8.1 vaccine doses
Pathogen-specific host responses define distinct pneumonia endotypes in the human lung
Cross-resistance patterns in SARS-CoV-2 against 3CL protease inhibitors
Exclusive: NIH ousts infectious-disease leaders as COVID scientists face US charges
Cross-resistance patterns in SARS-CoV-2 against 3CL protease inhibitors
Early antiviral use may lower risk of long COVID in mildly ill patients, aid recovery from infection
Virus in the vents: Study traces COVID spread in high-rise apartment
Antiviral ensitrelvir cuts risk of COVID-19 in household contacts by two-thirds, study finds